In the lung, the loss of AP-3-mediated trafficking of lamellar bodies in surfactant-producing alveolar type 2 cells contributes to a gain of function that results in the enhanced activation of repair pathways associated with pulmonary fibrosis in HPS2 [22], which is also a key feature of severe COVID-19. The gene discussed is AP3B1; the disease is pulmonary fibrosis.